An update to "The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe". Jit, M., Mangen, M. J, Melliez, H., Yazdanpanah, Y., Bilcke, J., Salo, H., Edmunds, W J., & Beutels, P. Vaccine, September, 2010.
An update to "The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe" [link]Paper  doi  abstract   bibtex   
A cost-effectiveness analysis of rotavirus vaccination in Belgium, England and Wales, Finland, France and the Netherlands published in 2009 was updated based on recent studies on rotavirus burden of disease and vaccine efficacy. All the qualitative conclusions in the previous study were found to remain valid. Vaccination remains cost-effective in Finland only when using plausible tender prices.
@article{jit_update_2010,
	title = {An update to "{The} cost-effectiveness of rotavirus vaccination: {Comparative} analyses for five {European} countries and transferability in {Europe}"},
	issn = {1873-2518},
	shorttitle = {An update to "{The} cost-effectiveness of rotavirus vaccination},
	url = {http://www.ncbi.nlm.nih.gov/pubmed/20846529},
	doi = {10.1016/j.vaccine.2010.08.060},
	abstract = {A cost-effectiveness analysis of rotavirus vaccination in Belgium, England and Wales, Finland, France and the Netherlands published in 2009 was updated based on recent studies on rotavirus burden of disease and vaccine efficacy. All the qualitative conclusions in the previous study were found to remain valid. Vaccination remains cost-effective in Finland only when using plausible tender prices.},
	urldate = {2010-10-03},
	journal = {Vaccine},
	author = {Jit, Mark and Mangen, Marie-Josée J and Melliez, Hugues and Yazdanpanah, Yazdan and Bilcke, Joke and Salo, Heini and Edmunds, W John and Beutels, Philippe},
	month = sep,
	year = {2010},
	pmid = {20846529},
	keywords = {*Rotavirus vaccine/do [Drug Dose], *Rotavirus vaccine/pe [Pharmacoeconomics], *vaccination, Belgium, Europe, Finland, France, Gastroenteritis, Hospitalization, Netherlands, comparative study, cost effectiveness analysis, drug efficacy, hospital infection, human, letter, priority journal, quality of life},
}

Downloads: 0